Comparison of neutrophil apoptosis α-defensins and calprotectin in children with and without severe early childhood caries

Iranian Journal of Immunology

Volumn 8, Issue 1, 2011, Pages 11-19

  Toomarian, Lida ^a   Sattari, Mandana ^a   Hashemi, Nazanin ^a   Tadayon, Nikoo ^a   Baghban, Alireza Akbarzadeh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calprotectin; Neutrophil Apoptosis; Severe Early Childhood Caries; Defensins

Indexed keywords

ALPHA DEFENSIN; CALGRANULIN; LIPOCORTIN 5; PROPIDIUM IODIDE;

ALPHA DEFENSIN SALIVA LEVEL; APOPTOSIS; ARTICLE; CALGRANULIN SALIVA LEVEL; CHILD; CONTROLLED STUDY; DENTAL CARIES; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUTH EXAMINATION; NEUTROPHIL; PRESCHOOL CHILD; SALIVA LEVEL; SALIVATION; SEVERE EARLY CHILDHOOD CARIES; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; IRAN; SALIVA;

ALPHA-DEFENSINS; APOPTOSIS; CHILD, PRESCHOOL; DENTAL CARIES; FEMALE; HUMANS; IRAN; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; NEUTROPHILS; SALIVA;

EID: 80052325217     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Drury TF, Horowitz AM, Ismail AI, Maertens MP, Rozier RG, Selwitz RH. Diagnosing and reporting early childhood caries for research purposes. A report of a workshop sponsored by the National Institute of Dental and Craniofacial Research, the Health Resources and Services Administration, and the Health Care Financing Administration. J Public Health Dent. 1999; 59:192-7.
2. Ismail AI, Sohn W. A systematic review of clinical diagnostic criteria of early childhood caries. J Public Health Dent. 1999; 59:171-91.
3. Cleaton-Jones P, Richardson BD, Granath L, Fatti LP, Sinwell R, Walker AR, et al. Nutritional status and dental caries in a large sample of 4- and 5-year-old South African children. S Afr Med J. 2000; 90:631-5.
4. Tao R, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, et al. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother. 2005; 49:3883-8.
5. Elbim C, Katsikis PD, Estaquier J. Neutrophil apoptosis during viral infections. Open Virol J. 2009; 3:52-9.
6. Aleman M, Schierloh P, de la Barrera SS, Musella RM, Saab MA, Baldini M, et al. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect Immun. 2004; 72:5150-8.
7. Ramirez MJ, Titos E, Claria J, Navasa M, Fernandez J, Rodes J. Increased apoptosis dependent on caspase-3 activity in polymorphonuclear leukocytes from patients with cirrhosis and ascites. J Hepatol. 2004; 41:44-8.
8. Delima AJ, Van Dyke TE. Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000. 2003; 31:55-76.
9. Hessian PA, Edgeworth J, Hogg N. MRP-8 and MRP-14, two abundant ca(2+) binding proteins of neutrophils and monocytes. J Leukoc Biol. 1993; 53:197-204.
10. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985; 76:1427-35.
11. Fleischmann J, Selsted ME, Lehrer RI. Opsonic activity of MCP-1 and MCP-2, cationic peptides from rabbit alveolar macrophages. Diagn Microbiol Infect Dis. 1985; 3:233-42.
12. Abiko Y, Saitoh M. Salivary defensins and their importance in oral health and disease. Curr Pharm. 2007; 13:3065-72.
13. Dale BA, Tao R, Kimball JR, Jurevic RJ. Oral antimicrobial peptides and biological control of caries. BMC Oral Health. 2006; 6 Suppl 1:S13.
14. Miyasaki KT, Bodeau AL, Murthy AR, Lehrer RI. In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena. J Dent Res. 1993; 72:517-23.
15. Murthy AR, Lehrer RI, Harwig SS, Miyasaki KT. In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol. 1993; 151:6291-301.
16. Hammer HB, Kvien TK, Glennas A, Melby K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin Exp Rheumatol. 1995; 13:59-64.
17. Cuida M, Halse AK, Johannessen AC, Tynning T, Jonsson R. Indicators of salivary gland inflammation in primary Sjogren's syndrome. Eur J Oral Sci. 1997; 105:228-33.
18. Kido J, Nakamura T, Kido R, Ohishi K, Yamauchi N, Kataoka M, et al. Calprotectin, a leukocyte protein related to inflammation, in gingival crevicular fluid. J Periodontal Res. 1998; 33:434-7.
19. Miyasaki KT, Voganatsi A, Huynh T, Marcus M, Underwood S. Calprotectin and lactoferin levels in the gingival crevicular fluid of children. J Perdiodontol. 1998; 69:879-83.
20. Kojima T, Anderson E, Sanchez JC, Wilkins MR, Hochstrasser DF, Pralong WF, et al. Human gingival cervicular fluid contains MRP8(S100A8) and MRP14(S100A9), two calcium-binding proteins of the S100 family. J Dent Res. 2000; 79:740-7.
21. Muller F, Froland SS, Brandtzaeg P, Fagerhol MK. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin Infect Dis. 1993; 16:301-2.
22. Cuida M, Brun JG, Tynning T, Jonsson R. Calprotectin levels in oral fluids: the importance of collection site. Eur J Oral Sci. 1995; 103:8-10.
23. Eversole LR, Miyasaki KT, Christensen RE. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J Oral Pathol Med. 1993; 22:303-7.
24. Schlegel Gomez R, Langer P, Pelka M, von den Driesch P, Johannessen AC, Simon M Jr. Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. J Clin Periodontol. 1995; 22:341-6.
25. World Health Organization. Oral health surveys: Basic methods. 4th ed. WHO: Geneva; 1997.
26. American Academy of Pediatric Dentistry: 2009-10 Definitions, oral health policies and clinical guidelines. Available from: URL: http://www.aapd.org/media/policies.asp.
27. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995; 184:39-51.
28. Jewett A, Hume WR, Le H, Huynh TN, Han YW, Cheng G, et al. Induction of apoptotic cell death in peripheral blood mononuclear and polymorphonuclear cells by an oral bacterium, Fusobacterium nucleatum. Infect Immun. 2000; 68:1893-8.
29. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980; 68:251-306.
30. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995; 267:1456-62.
31. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA. 1996; 93:2239-44.
32. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996; 87:13-20.
33. Fraser A, Evan G. A license to kill. Cell. 1996; 85:781-4.
34. Nagata S. Apoptosis by death factor. Cell. 1997; 88:355-65.
35. Chen Y, Zychlinsky A. Apoptosis induced by bacterial pathogens. Microb Pathog. 1994; 17:203-12.
36. Chen LM, Kaniga K, Galan JE. Salmonella spp. are cytotoxic for cultured macrophages. Mol Microbiol. 1996; 21:1101-15.
37. Chen Y, Smith MR, Thiyumalai K, Zychlinsky A. A bacterial invasion induces macrophage apoptosis by binding directly to ICE. EMBO J. 1996; 15:3853-60.
38. Monack DM, Raupach B, Hromockyj AE, Falkow S. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci USA. 1996; 93:9833-8.
39. Mizukawa N, Sugiyama K, Ueno T, Mishima K, Takagi S, Sugahara T. Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 87:539-43.
40. Schiott CR, Loe H. The origin and variation in number of leukocytes in the human saliva. J Periodontal Res. 1970; 5:36-41.
41. Seow W. Biological mechanisms of early childhood caries. Community Dent Oral Epidemiol. 1998; 26:8-27.
42. Mars WM, Patmasiriwat P, Maity T, Huff V, Weil MM, Saunders GF. Inheritance of unequal numbers of the genes encoding the human neutrophil defensins HP-1 and HP-3. J Biol Chem. 1995; 270:30371-6.
43. Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet. 2003; 73:591-600.
44. Reisine S, Douglas JM. Psychosocial and behavioral issues in early childhood caries. Community Dent Oral Epidemiol. 1998; 26:32-44.
45. Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull. 2003; 26:753-60.
46. Kirstila V, Hakkinen P, Jentsch H, Vilia P, Tenovuo J. Longitudinal analysis of the association of human salivary antimicrobial agents with caries increment and cariogenic microorganisms: a two-year cohort study. J Dent Res. 1998; 77:73-80
47. Van Nieuw Amerongen A, Bolscher JG, Veerman EC. Salivary proteins: protective and diagnostic value in cariology? Caries Res. 2004; 38:247-53.
48. Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol. 1995; 42:551-6.
49. Loomans HJ, Hahn BL, Li QQ, Phadnis SH, Sohnle PG. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J Infect Dis. 1998; 177:812-4.
50. Kido J, Nakamura T, Kido R, Ohishi K, Yamauchi N, Kataoka M, Nagata T. Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. J Clin Periodontol. 1999; 26:653-7.
51. Nakamura T, Kido J, Kido R, Ohishi K, Yamauchi N, Kataoka M, et al. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. J Periodontol. 2000; 71:361-7.
52. Nisapakultron K, Ross KF, Herzberg MC. Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect Immun. 2001; 69:4242-7.